We represent biotechnology, pharmaceutical and medical device companies, institutions, and investors in a wide range of sophisticated legal matters that arise in connection with the development, protection and commercialization of their diagnostic and therapeutic solutions.  Read More >

When professionals enter or exit employment, business, and independent contractor relationships, they look to us for guidance on key agreements, stock option grants, deferred compensation, and compliance with IRS code section 409A.  Read More >

Often lawyers or contracts specialists are asked to give a “quick” review of an incoming software license agreement on behalf of a prospective licensee. Read more for a checklist and short discussion of the main issues the reviewer should consider.  Read More >

Founders considering various fundraising options often ask the following question: Why should they take venture capital money, which may significantly dilute the founders’ equity and result in the founders’ loss of control of the company? Although the VC path is always a possibility, founders are often concerned about the consequences of such investments.  Read More >